CalciMedica Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: CalciMedica Inc.
Former names: Graybug Vision, INC. GRAYBUG, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: La Jolla
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CALC
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001534133
EIN: 45-2120079

Board of directors

Follow this board

A. Rachel Leheny · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Alan Glicklich · Director
Since 2025
Allan Shaw · Director
Since 2023
Christina Ackermann · Director
Since 2023
Christy L. Shaffer · Director
Since 2023
Dirk Sauer · Director
Since 2023
Eric Bjerkholt · Director
Since 2023
Eric W. Roberts · Director · CHIEF BUSINESS OFFICER
Since 2023
Evgeny Zaytsev · Director
Since 2026
Fred A. Middleton · Director
Since 2023
Frederic Guerard · Director · Chief Executive Officer
Since 2023
Julia Marie Eastland · Director
Since 2023
Robert N. Wilson · Director
Since 2023

Chief executives

A. Rachel Leheny · Chief Executive Officer

Since March 2023

Frederic Guerard · Chief Executive Officer

Until March 2023 · Former

Director election results

Annual meeting of August 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Allan Shaw

98.4%
Robert N. Wilson

99.7%

Board connections

3 of this board's directors also sit on 6 other boards. 6 are in the same sector.

Shared director Other board Same sector

Cerus Corporation Same sector
via Eric Bjerkholt
LENZ Therapeutics Inc. Same sector
via Frederic Guerard
Lantheus Holdings Inc. Same sector
via Julia Marie Eastland
Metagenomi Therapeutics Inc. Same sector
via Eric Bjerkholt
Surrozen Inc. Same sector
via Eric Bjerkholt
Zentalis Pharmaceuticals Inc. Same sector
via Julia Marie Eastland

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $199,178; 1 purchase by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 25, 2026	Fred A. Middleton Director, 10% owner	Open-market purchase	+248,972	$0.80	$199,178
Jun 25, 2026	Hebbar Sudarshan Officer (Chief Medical Officer)	Grant or award	+124,486	$0.80	$99,589
Jun 25, 2026	Robert N. Wilson Director	Grant or award	+1,182,621	$0.80	$946,097
Jun 25, 2026	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Grant or award	+186,729	$0.80	$149,383
Jun 25, 2026	A. Rachel Leheny Director, Officer (CHIEF EXECUTIVE OFFICER), 10% owner	Grant or award	+186,729	$0.80	$149,383
Sep 18, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+2,500	$3.07	$7,675
Sep 15, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+3,400	$2.68	$9,112
Sep 12, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+5,000	$3.12	$15,600
Sep 9, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+2,343	$3.15	$7,380
Aug 29, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+800	$2.74	$2,192
Aug 28, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+9,200	$2.86	$26,312
Aug 21, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+3,508	$2.79	$9,787
Aug 20, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+2,000	$2.72	$5,440
Aug 20, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Option exercise	+15,000	$1.53	$22,950
Aug 19, 2025	Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner	Open-market purchase	+1,000	$2.79	$2,790

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about CalciMedica Inc.

Who is the CEO of CalciMedica Inc.?

A. Rachel Leheny has been CalciMedica Inc.'s Chief Executive Officer since March 2023.

How many directors are on CalciMedica Inc.'s board?

CalciMedica Inc.'s board has 13 directors: A. Rachel Leheny, Alan Glicklich, Allan Shaw, Christina Ackermann, Christy L. Shaffer, Dirk Sauer, Eric Bjerkholt, Eric W. Roberts, Evgeny Zaytsev, Fred A. Middleton and 3 others.

Are CalciMedica Inc. insiders buying or selling shares?

Over the last 12 months, CalciMedica Inc. insiders bought $199,178 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is CalciMedica Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="calcimedica-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.